# Trillium Therapeutics Inc.

Trillium Therapeutics Inc. is a company headquartered in Mississauga, Canada.

## Company overview

- **Legal name:** Trillium Therapeutics Inc.
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Mississauga, Canada
- **Incorporated in:** A1
- **Fiscal year end:** December 31
- **SEC CIK:** 0001616212

## About

Trillium Therapeutics Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001616212, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2021-03-18, it reported annual revenue of USD 148,000; net income of USD -59,346,000; total assets of USD 300,822,000 for the fiscal period ended 2020-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2020 (period ended 2020-12-31)

- **Revenue:** $148,000 (USD 148,000)
- **Net income:** -$59.3M (USD -59,346,000)
- **Total assets:** $300.8M (USD 300,822,000)
- **Cash and equivalents:** $247.6M (USD 247,600,000)
- **Operating cash flow:** -$22.7M (USD -22,733,000)

### FY2019 (period ended 2019-12-31)

- **Revenue:** $124,000 (USD 124,000)
- **Net income:** -$41.6M (USD -41,622,000)
- **Total assets:** $25.4M (USD 25,407,000)
- **Cash and equivalents:** $14.6M (USD 14,584,000)
- **Operating cash flow:** -$24.9M (USD -24,908,000)

## Recent SEC filings

- Form 8-K — filed 2021-11-17 — period 2021-11-17 — FORM 8-K
- Form 8-K — filed 2021-11-16 — period 2021-11-15 — FORM 8-K
- Form 10-Q — filed 2021-11-12 — period 2021-09-30 — 10-Q
- Form 8-K — filed 2021-10-29 — period 2021-10-28 — FORM 8-K
- Form 8-K — filed 2021-10-27 — period 2021-10-26 — FORM 8-K
- Form 8-K — filed 2021-10-20 — period 2021-10-19 — FORM 8-K
- Form 8-K — filed 2021-10-15 — period 2021-10-13 — FORM 8-K
- Form 8-K — filed 2021-10-13 — period 2021-10-12 — FORM 8-K
- Form 8-K — filed 2021-08-23 — period 2021-08-20 — FORM 8-K
- Form 8-K — filed 2021-08-13 — period 2021-08-13 — 8-K
- Form 10-Q — filed 2021-08-13 — period 2021-06-30 — 10-Q
- Form 8-K — filed 2021-06-30 — period 2021-06-30 — FORM 8-K

---

Updated: 2026-10-23T20:12:17Z

Canonical page: https://altss.com/profile/trillium-therapeutics-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology